H. Hjelde

[Recurrence and survival after surgical treatment of lung cancer].

A. Ødegård, S. Hatlinghus, R. Haaverstad, 2010, Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke.

Phase III study by the Norwegian lung cancer study group: pemetrexed plus carboplatin compared with gemcitabine plus carboplatin as first-line chemotherapy in advanced non-small-cell lung cancer.

S. Kaasa, R. Bremnes, T. Amundsen, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Changes in skeletal muscle mass during palliative chemotherapy in patients with advanced lung cancer

S. Kaasa, J. Helbostad, T. Amundsen, 2015, Acta oncologica.

Vinorelbine/carboplatin vs gemcitabine/carboplatin in advanced NSCLC shows similar efficacy, but different impact of toxicity

R. Bremnes, C. von Plessen, N. Helbekkmo, 2007, British Journal of Cancer.

Influence of comorbidity on survival, toxicity and health-related quality of life in patients with advanced non-small-cell lung cancer receiving platinum-doublet chemotherapy.

S. Kaasa, R. Bremnes, T. Amundsen, 2010, European journal of cancer.

Increase in curative treatment and survival of lung cancer in Norway 2001–2016

B. Møller, Å. Helland, P. Haram, 2019, European Journal of Epidemiology.

Learning EBUS‐TBNA – a 6‐year experience at a single institution

T. Amundsen, S. Sørhaug, D. Nordhaug, 2016 .

Learning EBUS-TBNA – A 6-year experience at a single institution

T. Amundsen, S. Sørhaug, D. Nordhaug, 2015 .

Learning endobronchial ultrasound transbronchial needle aspiration – a 6‐year experience at a single institution

H. O. Leira, T. Amundsen, S. Sørhaug, 2018, The clinical respiratory journal.

Measurement of health-related quality of life during chemotherapy – the importance of timing

S. Kaasa, T. Amundsen, S. Sørhaug, 2017, Acta oncologica.

Measurement of health-related quality of life during chemotherapy – the importance of timing

S. Kaasa, T. Amundsen, S. Sørhaug, 2017, Acta oncologica.